Toth Financial Advisory’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-180
Closed -$44K 822
2022
Q3
$44K Sell
180
-1
-0.6% -$270 0.01% 281
2022
Q2
$45K Buy
181
+1
+0.6% +$270 0.01% 283
2022
Q1
$60K Hold
180
0.01% 269
2021
Q4
$65K Hold
180
0.01% 277
2021
Q3
$59K Hold
180
0.01% 291
2021
Q2
$56K Hold
180
0.01% 276
2021
Q1
$57K Hold
180
0.01% 284
2020
Q4
$58K Hold
180
0.01% 251
2020
Q3
$50K Hold
180
0.01% 242
2020
Q2
$43K Buy
+180
New +$36.1K 0.01% 234

Other funds holding ABMD

Toth Financial Advisory's ABMD Position: Q4 2022 in Review

Toth Financial Advisory sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 180 shares — an estimated $44K sold.

Toth Financial Advisory first reported a position in ABMD in Q2 2020 and held it in 10 quarters. The position peaked at $65K in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Toth Financial Advisory reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Toth Financial Advisory sold 180 Abiomed Inc shares in Q4 2022, an estimated $44K.
  • Toth Financial Advisory first reported a position in Abiomed Inc in Q2 2020 and held it in 10 quarters.
  • Toth Financial Advisory's Abiomed Inc position peaked at $65K in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Toth Financial Advisory's 13F filing for Q4 2022, filed 24 Jan 2023.